Rationale of a Cross-Sectional Descriptive Study on Temporal Evolution of Frequency, Risk Factors and Complications of Preeclampsia in the University Clinics of Kinshasa, DR Congo
Background: Knowledge of temporal evolution of
preeclampsia (PE) in its various aspects is essential in strategies to reduce
maternal and perinatal morbidity and mortality. Preeclampsia is a public health
problem due to maternal mortality associated with it worldwide (5.6%).
Improving quality of its management is a major challenge in low-income
countries where, despite progress made in this field, PE remains a major factor
in maternal morbidity and mortality. Objective: To evaluate temporal
evolution of frequency, risk factors and complications of PE at the University
clinics of Kinshasa (UCK). Methods: Descriptive and
cross-sectional study concerning minimum simple size of 119 pregnant women who consulted for antenatal care at the
University clinics of Kinshasa from January 2012 to December 2022. Results will
be reported as percentage proportion, mean and standard deviation. Comparison
of proportion and means between groups will be made using Student’s t-test and
Pearson’s chi-square test, respectively. The test will be statistically
significant for a p value ≤ less than 0.05. Data will be collected and
analysed anonymously and confidentially.Conclusion: This study will allow us to evaluate the
effectiveness of
References
[1]
Dimitriadis, E., Rolnik, D.L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R.P.V., et al. (2023) Pre-Eclampsia. Nature Reviews Disease Primers, 9, Article No. 8. https://doi.org/10.1038/s41572-023-00417-6
[2]
Brown, M.A., Magee, L.A., Kenny, L.C., Karumanchi, S.A., Mccarthy, F.P., Saito, S., et al. (2018) The Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis & Management Recommendations for International Practice.
[3]
Erez, O., Romero, R., Jung, E. and Chaemsaithong, P. (2022) Expert Review Preeclampsia and Eclampsia: The Conceptual Evolution of a Syndrome. American Journal of Obstetrics & Gynecology, 226, S786-S803.
https://doi.org/10.1016/j.ajog.2021.12.001
[4]
Phipps, E.A., Thadhani, R., Benzing, T., Karumanchi, S.A., Hospital, M.G., Sciences, B., et al. (2020) Pre-Eclampsia: Pathogenesis, Novel Diagnostics and Therapies. Nature Reviews Nephrology, 15, 275-289.
https://doi.org/10.1038/s41581-019-0119-6
[5]
Chappell, L.C., Cluver, C.A., Kingdom, J. and Tong, S. (2021). Pre-Eclampsia. Lancet, 398, 341-354. https://doi.org/10.1016/S0140-6736(20)32335-7
[6]
Elongi, J., Tandu, B., Spitz, B. and Verdonck, F. (2011) Influence of the Seasonal Variation on the Prevalence of Pre-Eclampsia in Kinshasa. Gynécologie Obstétrique & Fertilité, 39, 132-135. https://doi.org/10.1016/j.gyobfe.2010.12.010
[7]
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., Romero, R. and Services, H. (2018) Pre-Eclampsia Part 1: Current Understanding of Its Pathophysiology. Nature Reviews Nephrology, 10, 466-480. https://doi.org/10.1038/nrneph.2014.102
[8]
Benjelloun, A.T., Benchrifi, Y., Mahdaoui, S., Samouh, N., Hospitalier, C., Ibn, U., et al. (2020) Epidemiologie de la preeclampsie dans la region du grand Casablanca. PAMJ—Clinical Medicine, 2, Article No. 112.
https://doi.org/10.11604/pamj-cm.2020.2.112.20677
[9]
Poon, L.C., Shennan, A., Hyett, J.A., Kapur, A., Hadar, E., Divakar, H., et al. (2019) The International Federation of Gynecology and Obstetrics (FIGO) Initiative on Pre-Eclampsia: A Pragmatic Guide for First-Trimester Screening and Prevention. International Journal of Gynecology & Obstetrics, 145, 1-33.
https://doi.org/10.1002/ijgo.12802
[10]
Shamsi, U., Saleem, S. and Nishter, N. (2013) Epidemiology and Risk Factors of Preeclampsia; an Overview of Observational Studies. Al Ameen Journal of Medical Sciences, 6, 292-300.
[11]
WHO, USAID (2013) WHO Recommendations for the Prevention and Treatment of Preclampsia and Clampsia Implications and Actions.
[12]
Sole, K.B., Staff, A.C., Räisänen, S. and Laine, K. (2022) Substantial Decrease in Preeclampsia Prevalence and Risk over Two Decades: A Population-Based Study of 1,153,227 Deliveries in Norway. Pregnancy Hypertension, 28, 21-27.
https://doi.org/10.1016/j.preghy.2022.02.001
[13]
Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., et al. (2021) Epidemiological Trends of Maternal Hypertensive Disorders of Pregnancy at the Global, Regional, and National Levels: a Population-Based Study. BMC Pregnancy Childbirth, 21, Article No. 364. https://doi.org/10.1186/s12884-021-03809-2
[14]
Roberts, C.L., Ford, J.B., Algert, C.S., Antonsen, S., Chalmers, J., Cnattingius, S., et al. (2014) Population-Based Trends in Pregnancy Hypertension and Pre-Eclampsia: An International Comparative Study. BMJ Open, 1, e000101.
https://doi.org/10.1136/bmjopen-2011-000101
[15]
Amougou, S.N., Mbita, S., Danwe, D. and Tebeu, P.M. (2019) Factor Associated with Progression to Chronic Arterial Hypertension in Women with Preeclampsia in Yaoundé, Cameroon. The Pan African Medical Journal, 33, Article No. 200.
https://doi.org/10.11604/pamj.2019.33.200.16857
[16]
Njukang, N.E., Yoah, T.A., Sama, M., Obinchemti, E. and Kamgno, J. (2020) Prevalence and Risk Factors of Hypertensive Disorders in Pregnancy: Case of Mezam Division, NWR Cameroon. Journal of Women’s Health and Development, 3, 247-267. https://doi.org/10.26502/fjwhd.2644-28840035
[17]
Wallis, A.B., Saftlas, A.F., Hsia, J. and Atrash, H.K. (2008) Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004. American Journal of Hypertension, 21, 521-526.
https://doi.org/10.1038/ajh.2008.20
[18]
Klungsøyr, K., Morken, N.H., Irgens, L., Vollset, S.E. and Skjærven, R. (2012) Secular Trends in the Epidemiology of Pre-Eclampsia throughout 40 Years in Norway: Prevalence, Risk Factors and Perinatal Survival. Paediatric and Perinatal Epidemiology, 26, 190-198. https://doi.org/10.1111/j.1365-3016.2012.01260.x
[19]
You, S.H., Cheng, P.J., Chung, T.T., Kuo, C.F., Wu, H.M. and Chu, P.H. (2018) Population-Based Trends and Risk Factors of Early- and Late-Onset Preeclampsia in Taiwan 2001-2014. BMC Pregnancy Childbirth, 18, Article No. 199.
https://doi.org/10.1186/s12884-018-1845-7
[20]
Musa, J., Mohammed, C., Ocheke, A., Kahansim, M., Pam, V. and Daru, P. (2018) Incidence and Risk Factors for Pre-Eclampsia in Jos Nigeria. African Health Sciences, 18, 584-595. https://doi.org/10.4314/ahs.v18i3.16
[21]
Lisonkova, S., Sabr, Y., Mayer, C., Young, C., Skoll, A. and Joseph, K.S. (2014) Maternal Morbidity Associated with Early-Onset and Late-Onset Preeclampsia. Obstetrics & Gynecology, 124, 771-781. https://doi.org/10.1097/AOG.0000000000000472
[22]
Shahul, S., Tung, A., Minhaj, M., Nizamuddin, J., Wenger, J., Mahmood, E., et al. (2015) Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women with Preeclampsia/Eclampsia. Hypertension in Pregnancy, 34, 506-515. https://doi.org/10.3109/10641955.2015.1090581
[23]
Koual, M., Abbou, H., Carbonnel, M., Picone, O. and Ayoubi, J.M. (2013) Short-Term Outcome of Patients with Preeclampsia. Vascular Health and Risk Management, 9, 143-148. https://doi.org/10.2147/VHRM.S38970
[24]
Gottardi, E., Lecarpentier, E., Villette, C., Berman, A., Redel, D., Tsatsaris, V., et al. (2021) Preeclampsia before 26 Weeks of Gestation: Obstetrical Prognosis for the Subsequent Pregnancy. Journal of Gynecology Obstetrics and Human Reproduction, 50, Article ID: 102000. https://doi.org/10.1016/j.jogoh.2020.102000
[25]
Ajah, L.O., Ozonu, N.C., Ezeonu, P.O., Lawani, L.O., Obuna, J.A. and Onwe, E.O. (2016) The Feto-Maternal Outcome of Preeclampsia with Severe Features and Eclampsia in Abakaliki, South-East Nigeria. Journal of Clinical and Diagnostic Research, 10, QC18-QC21. https://doi.org/10.7860/JCDR/2016/21078.8499
[26]
Hortence, F.J., Manuella, M.W., Cliford, E.E., Agnès, E., Elodie, T.N., Florent, F.Y., et al. (2022) Factors Associated with Maternal and Perinatal Complications of Preeclampsia at the Central Hospital of Yaoundé: A Cross-Sectional Analytical Study. Open Journal of Obstetrics and Gynecology, 12, 1245-1257.
https://doi.org/10.4236/ojog.2022.1212109
[27]
Wang, X. and Ji, X. (2020) Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies. Supplement: An Overview of Study Design and Statistical Considerations, 158, S12-S20.
https://doi.org/10.1016/j.chest.2020.03.010
[28]
Mcclure, E.M. and Goldenberg, R.L. (2014) Factors and Prevention Strategies. The Journal of Maternal-Fetal & Neonatal Medicine, 22, 183-190.
https://doi.org/10.1080/14767050802559129
[29]
Ananth, C.V., Keyes, K.M. and Wapner, R.J. (2013) Pre-Eclampsia Rates in the United States, 1980-2010: Age-Period-Cohort Analysis. BMJ, 347, f6564.
https://doi.org/10.1136/bmj.f6564
[30]
Wagnew, M., Dessalegn, M., Worku, A. and Nyagero, J. (2016) Trends of Preeclampsia/Eclampsia and Maternal and Neonatal Outcomes among Women Delivering in Addis Ababa Selected Government Hospitals, Ethiopia: A Retrospective Cross-Sectional Study. The Pan African Medical Journal, 25, Article No. 12.
[31]
Adwoa, N., Kunfah, J.A., Akayuure, C.A., Kappiah, J.B. and Kampo, S. (2022) Prevalence and Demographic Distribution Associated with Pre-Eclampsia among Pregnant Women at a Local Teaching Hospital in Ghana. Journal of Anesthesia and Perioperative Medicine, 2, Article No. 107.
https://doi.org/10.36879/APM.2022.000107
[32]
Paré, E., Parry, S., McElrath, T.F., Pucci, D., Newton, A. and Lim, K.H. (2014) Clinical Risk Factors for Preeclampsia in the 21st Century. Obstetrics & Gynecology, 124, 763-770. https://doi.org/10.1097/AOG.0000000000000451
[33]
Kooffreh, M., Ekott, M. and Ekpoudom, D. (2014) The Prevalence of Pre-Eclampsia among Pregnant Women in the University of Calabar Teaching Hospital, Calabar. Saudi Journal for Health Sciences, 3, 133-136.
https://doi.org/10.4103/2278-0521.142317
[34]
Guerrier, G., Oluyide, B., Keramarou, M. and Grais, R.F. (2013) Factors Associated with Severe Preeclampsia and Eclampsia in Jahun, Nigeria. International Journal of Women’s Health, 5, 509-513. https://doi.org/10.2147/IJWH.S47056
